Nalls Sherbakoff Group’s Sanofi SNY Stock Holding History

Nalls Sherbakoff Group’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.8K	Hold	300	–	–	0.01%	264
2026 Q1	$14.5K	Hold	300	–	–	0.01%	283
2025 Q4	$14.5K	Hold	300	–	–	0.01%	300
2025 Q3	$14.2K	Hold	300	–	–	0.01%	302
2025 Q2	$14.5K	Hold	300	–	–	0.01%	302
2025 Q1	$16.6K	Buy	+300	New	+$16.2K	0.01%	263
2023 Q4	$14.9K	Hold	300	–	–	0.01%	254
2023 Q3	$16.1K	Hold	300	–	–	0.02%	241
2023 Q2	$15.3K	Hold	300	–	–	0.02%	247
2023 Q1	$16.2K	Buy	+300	New	+$14.6K	0.02%	247
2018 Q4	$13K	Buy	+300	New	+$13.2K	0.02%	250

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Nalls Sherbakoff Group's SNY Position: Q2 2026 in Review

Nalls Sherbakoff Group held its Sanofi (SNY) position steady in Q2 2026 at 300 shares worth $12.8K. The position accounts for 0.01% of the portfolio, ranked #264.

Nalls Sherbakoff Group first reported a position in SNY in Q4 2018 and has held it in 11 quarters since. The position peaked at $16.6K in Q1 2025. 718 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

Nalls Sherbakoff Group held 300 shares of Sanofi worth $12.8K as of Q2 2026.
Nalls Sherbakoff Group left its Sanofi share count unchanged in Q2 2026.
Sanofi made up 0.01% of Nalls Sherbakoff Group's portfolio in Q2 2026, its #264 holding.
Nalls Sherbakoff Group first reported a position in Sanofi in Q4 2018 and has held it in 11 quarters since.
Nalls Sherbakoff Group's Sanofi position peaked at $16.6K in Q1 2025.
718 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Nalls Sherbakoff Group's 13F filing for Q2 2026, filed 17 Aug 2026.